These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 7832132)
1. Coronary microvascular response to intracoronary administration of nicorandil. Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132 [TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism. Nakae I; Matsumoto T; Horie H; Yokohama H; Omura T; Minai K; Matsui T; Nozawa M; Takahashi M; Sugimoto Y; Ito M; Izumi M; Nakamura Y; Mitsunami K; Kinoshita M J Cardiovasc Pharmacol; 2000 Jun; 35(6):919-25. PubMed ID: 10836727 [TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine on human coronary arterial circulation. Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364 [TBL] [Abstract][Full Text] [Related]
4. Effective and safe dose of intracoronary nicorandil in man. Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation. Nishikawa Y; Kanki H; Ogawa S J Cardiovasc Pharmacol; 1998 Jul; 32(1):21-8. PubMed ID: 9676716 [TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine triphosphate on human coronary circulation. Shiode N; Kato M; Nakayama K; Shinohara K; Kurokawa J; Yamagata T; Matsuura H; Kajiyama G Intern Med; 1998 Oct; 37(10):818-25. PubMed ID: 9840701 [TBL] [Abstract][Full Text] [Related]
7. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Wilson RF; White CW Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model. Duan T; Zhang J; Xiang D; Song R; Kong R; Xu D Adv Clin Exp Med; 2019 Oct; 28(10):1409-1418. PubMed ID: 31638745 [TBL] [Abstract][Full Text] [Related]
9. Coronary vasodilatory action after a single dose of nicorandil. Suryapranata H; Serruys PW; De Feyter PJ; Verdouw PD; Hugenholtz PG Am J Cardiol; 1988 Feb; 61(4):292-7. PubMed ID: 2963519 [TBL] [Abstract][Full Text] [Related]
11. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil. Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221 [TBL] [Abstract][Full Text] [Related]
12. Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine. Inoue F; Hashimoto T; Fujimoto S; Uemura S; Kawamoto A; Dohi K Heart Vessels; 1998; 13(5):229-36. PubMed ID: 10483772 [TBL] [Abstract][Full Text] [Related]
13. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve. Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477 [TBL] [Abstract][Full Text] [Related]
14. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin. Aizawa T; Ogasawara K; Kato K J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419 [TBL] [Abstract][Full Text] [Related]
15. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522 [TBL] [Abstract][Full Text] [Related]
16. Effects of various doses of intracoronary verapamil on coronary resistance vessels in humans. Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K; Ueda K Jpn Circ J; 1997 Sep; 61(9):755-61. PubMed ID: 9293405 [TBL] [Abstract][Full Text] [Related]
18. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve. Zijlstra F; Juillière Y; Serruys PW; Roelandt JR Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211 [TBL] [Abstract][Full Text] [Related]
19. [Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine]. Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Hirozane T; Himura Y; Iga K; Gen H; Konishi T J Cardiol; 2000 Mar; 35(3):175-80. PubMed ID: 10808424 [TBL] [Abstract][Full Text] [Related]
20. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease. Kishida H; Hata N; Kusama Y; Iwahara S; Sasaki Y; Mori N; Yasutake M; Koumi S; Takayama M; Munakata K Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]